NATCO Pharma Limited (NATCOPHARM.BO)
INR 771.25
(0.63%)
INR 771.25
(0.63%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 7 Billion INR | -5.71% |
| 2022 | 7.42 Billion INR | -2.51% |
| 2021 | 7.62 Billion INR | -4.54% |
| 2020 | 7.98 Billion INR | 43.05% |
| 2019 | 5.58 Billion INR | 5.48% |
| 2018 | 5.29 Billion INR | 20.67% |
| 2017 | 4.38 Billion INR | 25.65% |
| 2016 | 3.48 Billion INR | -2.35% |
| 2015 | 3.57 Billion INR | 62.41% |
| 2014 | 2.2 Billion INR | 21.46% |
| 2013 | 1.81 Billion INR | 24.04% |
| 2012 | 1.46 Billion INR | 32.28% |
| 2011 | 1.1 Billion INR | 7.98% |
| 2010 | 1.02 Billion INR | 32.02% |
| 2009 | 774.35 Million INR | -3.56% |
| 2008 | 802.94 Million INR | 17.48% |
| 2007 | 683.49 Million INR | 32.23% |
| 2006 | 516.88 Million INR | 12.97% |
| 2005 | 457.51 Million INR | 20.4% |
| 2004 | 380.01 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 7 Billion INR | -5.71% |
| 2023 Q4 | 7 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 7.09 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 7.42 Billion INR | 0.0% |
| 2022 FY | 7.42 Billion INR | -2.51% |
| 2022 Q2 | 7.49 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 7.62 Billion INR | -4.54% |
| 2021 Q2 | 9.14 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 7.62 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 7.98 Billion INR | 0.0% |
| 2020 FY | 7.98 Billion INR | 43.05% |
| 2020 Q2 | 6.71 Billion INR | 0.0% |
| 2019 FY | 5.58 Billion INR | 5.48% |
| 2019 Q2 | 5.15 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 5.58 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 5.29 Billion INR | 0.0% |
| 2018 Q2 | 4.77 Billion INR | 0.0% |
| 2018 FY | 5.29 Billion INR | 20.67% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q2 | 3.86 Billion INR | 0.0% |
| 2017 Q4 | 4.38 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 4.38 Billion INR | 25.65% |
| 2016 Q2 | 4.23 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 3.48 Billion INR | -2.35% |
| 2016 Q4 | 3.48 Billion INR | 0.0% |
| 2015 Q2 | 2.74 Billion INR | 0.0% |
| 2015 FY | 3.57 Billion INR | 62.41% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 3.57 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q2 | 1.77 Billion INR | 0.0% |
| 2014 FY | 2.2 Billion INR | 21.46% |
| 2014 Q4 | 2.2 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q4 | 1.81 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 FY | 1.81 Billion INR | 24.04% |
| 2013 Q2 | 1.5 Billion INR | 0.0% |
| 2012 Q4 | 1.46 Billion INR | 0.0% |
| 2012 FY | 1.46 Billion INR | 32.28% |
| 2012 Q2 | 1.25 Billion INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2011 Q4 | 1.1 Billion INR | 0.0% |
| 2011 FY | 1.1 Billion INR | 7.98% |
| 2010 FY | 1.02 Billion INR | 32.02% |
| 2009 FY | 774.35 Million INR | -3.56% |
| 2008 FY | 802.94 Million INR | 17.48% |
| 2007 FY | 683.49 Million INR | 32.23% |
| 2006 FY | 516.88 Million INR | 12.97% |
| 2005 FY | 457.51 Million INR | 20.4% |
| 2004 FY | 380.01 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 57.379% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 92.858% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -5.087% |
| Granules India Limited | 13 Billion INR | 46.138% |
| Indoco Remedies Limited | 3.53 Billion INR | -98.408% |
| Achyut Healthcare Limited | 568 Thousand INR | -1233174.648% |
| Ajanta Pharma Limited | 8.28 Billion INR | 15.435% |
| Alkem Laboratories Limited | 26.61 Billion INR | 73.677% |
| Alpa Laboratories Limited | 136.65 Million INR | -5026.122% |
| Brooks Laboratories Limited | 96.1 Million INR | -7188.675% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -207.396% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -386.329% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -491.402% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 88.978% |
| Eris Lifesciences Limited | 1.89 Billion INR | -270.572% |
| FDC Limited | 3.88 Billion INR | -80.129% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 72.126% |
| Gufic Biosciences Limited | 2 Billion INR | -249.408% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -6598.414% |
| Ipca Laboratories Limited | 24.71 Billion INR | 71.655% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -4570.934% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -7050.586% |
| Lasa Supergenerics Limited | 190.43 Million INR | -3578.44% |
| Laurus Labs Limited | 18.45 Billion INR | 62.041% |
| Lupin Limited | 49.53 Billion INR | 85.86% |
| Mankind Pharma Limited | 15.53 Billion INR | 54.907% |
| Medicamen Biotech Limited | 593.75 Million INR | -1079.785% |
| Medico Remedies Limited | 163.37 Million INR | -4187.76% |
| Megasoft Limited | - INR | -Infinity% |
| Piramal Pharma Limited | 21.75 Billion INR | 67.806% |
| RPG Life Sciences Limited | 1.01 Billion INR | -593.564% |
| Sigachi Industries Limited | 707.2 Million INR | -890.516% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 92.902% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -202.99% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -3222.819% |
| Unichem Laboratories Limited | 7.04 Billion INR | 0.593% |
| Wanbury Limited | 360.23 Million INR | -1844.58% |
| Windlas Biotech Limited | 621.89 Million INR | -1026.405% |
| ZIM Laboratories Limited | 812.62 Million INR | -762.017% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 79.648% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 77.999% |
| Hester Biosciences Limited | 755.81 Million INR | -826.82% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -542.013% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -2323.481% |
| Bal Pharma Limited | 878.11 Million INR | -697.732% |
| Strides Pharma Science Limited | 11.26 Billion INR | 37.802% |
| Venus Remedies Limited | 1.21 Billion INR | -475.643% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -8.966% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 1.22% |
| Shilpa Medicare Limited | 3.44 Billion INR | -103.086% |
| Aarti Drugs Limited | 4.85 Billion INR | -44.168% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -64.886% |
| Suven Life Sciences Limited | 7.08 Million INR | -98770.854% |
| Ind-Swift Limited | 640.91 Million INR | -992.969% |
| Valiant Laboratories Limited | 100.15 Million INR | -6894.229% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -39.4% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -94.746% |
| Themis Medicare Limited | 705.74 Million INR | -892.571% |
| Hikal Limited | 3.03 Billion INR | -130.64% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 69.263% |
| Sequent Scientific Limited | 3.46 Billion INR | -102.321% |
| Novartis India Limited | 448.6 Million INR | -1461.525% |
| Wockhardt Limited | 6.4 Billion INR | -9.453% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 45.681% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -27373.82% |
| Neuland Laboratories Limited | 3.5 Billion INR | -99.902% |
| Morepen Laboratories Limited | 2.48 Billion INR | -181.785% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -17465.196% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -466.565% |